Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CASR | P41180 | 1/20 | 0.46 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31226473 | 1.00 | MMP2 (0.55) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| SCHEMBL27995741 | 0.98 | MMP2 (0.53) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| Hydrochloric Acid SCHEMBL29744423 | 0.98 | MMP2 (0.53) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| SCHEMBL39857 | 0.86 | ALDH1A1 (0.55) | ALDH1A1HSD17B10KDM4EMAPK1HPGD | |
| SCHEMBL8718150 | 0.85 | ALDH1A1 (0.72) | MMP2ALDH1A1HSD17B10KDM4EHPGD | |
| Mesalamine SCHEMBL8720354 | 0.85 | ALDH1A1 (0.61) | MMP2ALDH1A1HSD17B10KDM4EHPGD | |
| SCHEMBL9818242 | 0.85 | ALDH1A1 (0.48) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| SCHEMBL7106629 | 0.85 | ALDH1A1 (0.48) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| SCHEMBL29430315 | 0.85 | ALDH1A1 (0.48) | MMP2ALDH1A1HSD17B10CFTRKDM4E | |
| Hydrochloric Acid SCHEMBL699717 | 0.84 | ALDH1A1 (0.53) | ALDH1A1HSD17B10KDM4EMAPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110997810-A | Electrically conductive biomaterials comprising benzoic acid based polymers for enhancing tissue conductivity in vitro and in vivo | 大学健康网络 | 2020-04-10 | — | — | CN | claimed |
| US-10385096-B2 | Pro-Amb reverse turn restricted bioactive peptide analogues | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-08-20 | — | — | US | claimed |
| US-20180273819-A1 | THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS COMPRISING TRIAMINES AND METHODS FOR MAKING AND USING THEM | ENTROPY SOLUTIONS LLC (US) | 2018-09-27 | — | — | US | claimed |
| US-20180057529-A1 | PRO-AMB REVERSE TURN RESTRICTED BIOACTIVE PEPTIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-03-01 | — | — | US | claimed |
| WO-2016179028-A1 | THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS AND METHODS FOR MAKING AND USING THEM | ENTROPY SOLUTIONS, LLC. (US) | 2016-11-10 | — | — | WO | claimed |
| WO-2003016615-A1 | SINGLE BATH PROCESS FOR BLEACHING AND DYEING TEXTILES | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| EP-4709712-A1 | GSK3A INHIBITORS AND METHODS OF USE THEREOF | Blueprint Medicines Corporation (US) | 2026-03-18 | — | — | EP | disclosed |
| CN-114057651-B | Amide group-containing TYK2 inhibitor compounds | 正大天晴药业集团股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-3848370-B1 | TYK2 INHIBITORS AND USES THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2025-05-07 | — | — | EP | disclosed |
| CN-114907326-B | TYK2 inhibitor compounds containing an amide group and a bicyclic ring | 正大天晴药业集团股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20240425456-A1 | DEGRADER | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2024-12-26 | — | — | US | disclosed |
| WO-2024233900-A1 | GSK3A INHIBITORS AND METHODS OF USE THEREOF | BLUEPRINT MEDICINES CORPORATION (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4410806-A1 | DEGRADATION INDUCER | ASKA Pharmaceutical Co., Ltd. (JP) | 2024-08-07 | — | — | EP | disclosed |
| US-5498618-A | ANTAGONISM OF 5-HT2 | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-03-12 | — | — | US | disclosed |
| EP-0650475-A1 | 4-AMINO-N --(4-METHYL-4-PIPERIDINYL)-2-METHOXYBENZAMIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1995-05-03 | — | — | EP | disclosed |
| WO-1994002462-A1 | 4-AMINO-N^_-(4-METHYL-4-PIPERIDINYL)-2-METHOXYBENZAMIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-02-03 | — | — | WO | disclosed |
| EP-0190915-B1 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1992-10-28 | — | — | EP | disclosed |
| US-4870181-A | AMIDATION OF 3-AMINOQUINUCLIDINE SALT | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-09-26 | — | — | US | disclosed |
| EP-0190915-A2 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1986-08-13 | — | — | EP | disclosed |
| US-4036951-A | SUNSCREEN AGENTS | SYNERGISTICS, INC. (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425456-A1 | DEGRADER | JAK3, JAK1, JAK2 | MMP2 1847/4885ALDH1A1 4053/4885HSD17B10 2068/4885 |
| US-20180057529-A1 | PRO-AMB REVERSE TURN RESTRICTED BIOACTIVE PEPTIDE ANALOGUES | APP, FURIN, PREP | MMP2 960/4885ALDH1A1 4716/4885HSD17B10 2463/4885 |
| US-10385096-B2 | Pro-Amb reverse turn restricted bioactive peptide analogues | APP, FURIN, PREP | MMP2 1003/4885ALDH1A1 4702/4885HSD17B10 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.